Author

T. Seno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:development & morphogenesis· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

A. Kuo· 2 shared S. Swendeman· 2 shared T. Hla· 2 shared A. Cartier· 1 shared A. Culbertson· 1 shared A. Inoue· 1 shared A. Schmaier· 1 shared B. Jung· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

A. Kuo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Therapeutic activation of endothelial sphingosine 1-phosphate receptor-1 by chaperone-bound S1P suppresses proliferative retinal vasculopathy

C. Niaudet, B. Jung, A. Kuo, S. Swendeman, E. Bull, T. Seno, R. Crocker, Z. Fu, L. E. H. Smith, T. Hla

The paper shows that activating endothelial S1PR1 with HDL-bound S1P or a Gi-biased agonist suppresses neovascular tufts in retinopathy models.

bioRxiv · Jun 14, 2022 · PreprintPathology

Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to combat endothelial dysfunction and thromboinflammation

S. Swendeman, D. Lin, S. Guo, A. Culbertson, A. Kuo, M. Levesque, A. Cartier, T. Seno, A. Schmaier, S. Galvani, A. Inoue, S. Parikh, G. A. FitzGerald, M. Liao, R. Flaumenhaft, T. Hla

This paper constructs engineered HDL-like particles that chaperone bioactive lipids to reduce inflammation and endothelial dysfunction.

bioRxiv · Feb 14, 2022 · PreprintBiochemistry